XML 95 R83.htm IDEA: XBRL DOCUMENT v3.20.2
BUSINESS COMBINATIONS (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 10 Months Ended
Aug. 11, 2020
Apr. 30, 2020
Mar. 31, 2020
Aug. 31, 2019
Jun. 30, 2019
Jul. 03, 2020
Apr. 03, 2020
Jan. 03, 2020
Sep. 27, 2019
Jun. 28, 2019
Mar. 29, 2019
Jul. 03, 2020
Jun. 28, 2019
Mar. 31, 2020
Business Acquisition [Line Items]                            
Increase (decrease) in goodwill due to period adjustments                       $ (1,800,000)    
Payment of contingent consideration                       11,200,000 $ 500,000  
Goodwill acquired                       2,600,000    
Acquisition-related expenses           $ 3,800,000       $ 10,400,000   12,100,000 $ 15,000,000.0  
Embolics Microspheres Business                            
Business Acquisition [Line Items]                            
Cash consideration       $ 90,000,000.0                    
Cancer Treatment Services International                            
Business Acquisition [Line Items]                            
Increase (decrease) in goodwill due to period adjustments           (5,500,000)                
Increase (decrease) in deferred tax liabilities due to period adjustments           (5,500,000)                
Cash consideration         $ 262,800,000                  
Acquisition purchase price         277,000,000.0                  
Contingent consideration liability         8,200,000                  
Change to fair value of contingent consideration liability     $ 8,200,000                      
Other consideration         6,000,000.0                  
Undiscounted range of contingent consideration payments, low         0                  
Undiscounted range of contingent consideration payments, high         $ 58,000,000                  
Revenue projection period for consideration payments         18 months                  
Endocare and Alicon                            
Business Acquisition [Line Items]                            
Increase (decrease) in goodwill due to period adjustments           3,800,000                
Increase (decrease) in deferred tax liabilities due to period adjustments           3,800,000                
Cash consideration         $ 197,400,000                  
Acquisition purchase price         210,000,000.0                  
Contingent consideration liability         $ 12,600,000 $ 40,000,000.0           $ 40,000,000.0    
Change to fair value of contingent consideration liability             $ 8,800,000 $ 18,600,000            
Undiscounted range of contingent consideration payments, low                           $ 0
Undiscounted range of contingent consideration payments, high                           $ 40,000,000
Payment of contingent consideration   $ 10,000,000                        
Endocare and Alicon | Subsequent Event                            
Business Acquisition [Line Items]                            
Payment of contingent consideration $ 30,000,000                          
Privately-held Company                            
Business Acquisition [Line Items]                            
Asset acquisition, purchase price                 $ 15,200,000          
Asset acquisition, holdback amount                 3,600,000          
Asset acquisition, fair value of contingent consideration                 0          
Asset acquisition, potential maximum payout of contingent consideration                 $ 9,000,000          
Privately-held Software Company                            
Business Acquisition [Line Items]                            
Acquisition purchase price                     $ 28,500,000      
Goodwill acquired                     21,900,000      
Intangible assets                     $ 6,500,000